Lipella Pharmaceuticals announced the expansion of its Scientific Advisory Board to include oncology expertise. The new committee members are: Jason Hafron, MD, DDS, PhD, MPH, the Chief Medical Officer at Michigan Institute of Urology, and Professor of Urology at the William Beaumont School of Medicine; and Pradeep Tyagi, PhD, MBA, Professor of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA. Drs. Hafron and Tyagi have complementing expertise in both clinical and translational research in cancer treatment, with a focus on urologic oncology.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LPLA:
- LPL Financial: Philip Nation joins broker-dealer, RIA, custodial platforms
- LPL Financial Welcomes Advisor Philip Nation
- LPL Financial Welcomes Strategic Insights Financial Planning Group
- LPL Financial: Strategic Insights joins broker-dealer, RIA, custodial platforms
- LPL Financial Welcomes Somnio Wealth
